Aurobindo Pharma is reportedly planning to expand its footprint in newer markets in the European Union. The Hyderabad-based company intends to consolidate its position and presence among the top 10 companies in Europe.
The proposed expansion will not just be in new markets such as Poland and Czech Republic, but there will also be portfolio expansion through targeted first day launches in orals, hormonals, penems, oncology drugs and niche injectables, among others, according to the information shared in its latest investor presentation.
